SCHEMBL10624311

SCHEMBL10624311

CN1CCN(C2=Nc3ccccc3N3CCc4cc(Cl)cc2c43)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 12/20 0.53
▸ DRD1 P21728 8/20 0.53
▸ HRH4 Q9H3N8 7/20 0.53
▸ DRD4 P21917 6/20 0.53
▸ CHRM1 P11229 4/20 0.53
▸ DRD3 P35462 4/20 0.53
▸ HRH1 P35367 4/20 0.53
▸ CHRM2 P08172 3/20 0.53
▸ HTR1A P08908 3/20 0.53
▸ ADRA2A P08913 3/20 0.53
▸ ADRA2B P18089 3/20 0.53
▸ ADRA2C P18825 3/20 0.53
▸ CHRM3 P20309 3/20 0.53
▸ SLC6A2 P23975 3/20 0.53
▸ HTR2A P28223 3/20 0.53
▸ HTR2C P28335 3/20 0.53
▸ SLC6A4 P31645 3/20 0.53
▸ ADRA1A P35348 3/20 0.53
▸ OPRD1 P41143 3/20 0.53
▸ HTR2B P41595 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10620912 0.89 DRD2 (0.58) DRD2DRD1HRH4DRD4CHRM1
SCHEMBL10620758 0.87 HRH4 (0.47) DRD2DRD1HRH4DRD4CHRM1
SCHEMBL10625693 0.87 PAK1 (0.49) DRD2DRD1HRH4DRD4CHRM1
SCHEMBL10620821 0.86 HRH4 (0.46) DRD2DRD1HRH4DRD4CHRM1
SCHEMBL10623820 0.86 DRD2 (0.61) DRD2DRD1HRH4DRD4CHRM1
SCHEMBL10625295 0.86 PAK1 (0.48) DRD2DRD1HRH4DRD4CHRM1
SCHEMBL10620991 0.83 HRH4 (0.56) DRD2DRD1HRH4DRD4LMNA
SCHEMBL11446142 0.82 DRD2 (0.37) DRD2DRD1HRH4DRD4CHRM1
Hydrochloric Acid SCHEMBL11445376 0.81 DRD2 (0.36) DRD2DRD1HRH4DRD4CHRM1
SCHEMBL10674331 0.81 HRH4 (0.45) DRD2DRD1HRH4DRD4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4761412-A Benzopyrrolobenzodiazepines and quinobenzodiazepines useful for the treatment of psychoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 — — US claimed
US-4663453-A Benzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepines having dopamine receptor activity HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-05-05 — — US claimed
US-4764616-A ANALGESIC, ANTIPHYCHOTIC HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-16 — — US disclosed
US-4761412-A Benzopyrrolobenzodiazepines and quinobenzodiazepines useful for the treatment of psychoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 — — US disclosed
US-4761411-A Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 — — US disclosed
US-4723003-A ANTIPSYCHOTIC AGENTS, ANALGESICS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-02-02 — — US disclosed
US-4723007-A ANALGESICS, ANTIPSYCHOTIC AGENTS; INTERMEDIATES FOR PROCESSING HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-02-02 — — US disclosed
US-4663453-A Benzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepines having dopamine receptor activity HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-05-05 — — US disclosed
EP-0129692-A2 Dibenzodiazepin derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-01-02 — — EP disclosed
Send feedback